Thromboxane Prostaglandin Receptor Antagonist and Carotid Atherosclerosis Progression in Patients With Cerebrovascular Disease of Ischemic Origin: A Randomized Controlled Trial [Clinical Sciences]

Conclusions— Compared with aspirin, Terutroban did not beneficially affect progression of carotid atherosclerosis among well-treated patients with a history of ischemic stroke or transient ischemic attacks with an internal carotid stenosis <70%. Clinical Trial Registration— URL: http://www.controlled-trials.com. Unique identifier: ISRCTN66157730.

http://stroke.ahajournals.org/cgi/content/short/45/8/2348?rss=1

Source: Stroke - July 28, 2014 Category: Neurology Authors: Bots, M. L., Ford, I., Lloyd, S. M., Laurent, S., Touboul, P. J., Hennerici, M. G., on behalf of the Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin With Terutroban in Patients With a History of Ischemic Stroke or Transient Isch Tags: Secondary prevention, Imaging, Antiplatelets Clinical Sciences Source Type: research